Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy B Stamm

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Biotechniques|May 27, 2003
One-step cellular caspase-3/7 assayRosa A Carrasco, Nancy B Stamm, Bharvin K R Patel
Molecular Cancer Therapeutics|January 11, 2011
Antisense inhibition of survivin expression as a cancer therapeuticRosa A Carrasco, Nancy B Stamm, Eric Marcusson, et al.
Bioorganic & Medicinal Chemistry Letters|May 20, 2004
1,7-annulated indolocarbazoles as cyclin-dependent kinase inhibitorsRima S Al-awar, James E Ray, Kyle A Hecker, et al.
Bioorganic & Medicinal Chemistry Letters|June 26, 2003
Novel, potent and selective cyclin D1/CDK4 inhibitors: indolo[6,7-a]pyrrolo[3,4-c]carbazolesThomas A Engler, Kelly Furness, Sushant Malhotra, et al.
Molecular Cancer Therapeutics|January 30, 2004
The discovery of a new structural class of cyclin-dependent kinase inhibitors, aminoimidazo[1,2-a]pyridinesChafiq Hamdouchi, Heather Keyser, Elizabeth Collins, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Biotechniques|May 27, 2003
One-step cellular caspase-3/7 assayRosa A Carrasco, Nancy B Stamm, Bharvin K R Patel
Molecular Cancer Therapeutics|January 11, 2011
Antisense inhibition of survivin expression as a cancer therapeuticRosa A Carrasco, Nancy B Stamm, Eric Marcusson, et al.
Bioorganic & Medicinal Chemistry Letters|May 20, 2004
1,7-annulated indolocarbazoles as cyclin-dependent kinase inhibitorsRima S Al-awar, James E Ray, Kyle A Hecker, et al.
Bioorganic & Medicinal Chemistry Letters|June 26, 2003
Novel, potent and selective cyclin D1/CDK4 inhibitors: indolo[6,7-a]pyrrolo[3,4-c]carbazolesThomas A Engler, Kelly Furness, Sushant Malhotra, et al.
Molecular Cancer Therapeutics|January 30, 2004
The discovery of a new structural class of cyclin-dependent kinase inhibitors, aminoimidazo[1,2-a]pyridinesChafiq Hamdouchi, Heather Keyser, Elizabeth Collins, et al.
Pageof 1